Antibiotic resistance in patients with primary immunodeficiency disorders versus immunocompetent patients

References

• Notarangelo L, Casanova JL, Fischer A, et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 2004;114(3):677-87
   PubMed Web of Science ®Google Scholar
• Khodadad A, Aghamohammadi A, Parvaneh N, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007;52(11):2977-8
   PubMed Web of Science ®Google Scholar
• Freeman AF, Holland SM. Antimicrobial prophylaxis for primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2009;9(6):525-30
   PubMed Web of Science ®Google Scholar
• Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract 2013;1(6):573-82
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003;36(11):1433-7
   PubMed Web of Science ®Google Scholar
• Mauldin PD, Salgado CD, Hansen IS, et al. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother 2010;54(1):109-15
   PubMed Web of Science ®Google Scholar
• Smith RD, Yago M, Millar M, et al. Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance. J Health Econ 2005;24(6):1055-75
   PubMed Web of Science ®Google Scholar
• Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005;5(8):481-93
   PubMed Web of Science ®Google Scholar
• Okeke IN, Klugman KP, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis 2005;5(9):568-80
   PubMed Web of Science ®Google Scholar
• Andrews TM. Current concepts in antibiotic resistance. Curr Opin Otolaryngol Head Neck Surg 2003;11(6):409-15
   PubMedGoogle Scholar
• Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child 2011;96(6):590-5
   PubMed Web of Science ®Google Scholar
• Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93(3):190-7
   PubMed Web of Science ®Google Scholar
• Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011;2:54
   PubMed Web of Science ®Google Scholar
• Rezaei N, Aghamohammadi A, Moin M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol 2006;6):519-32
   PubMed Web of Science ®Google Scholar
• Haghi Ashtiani MT, Mamishi S, Masoomi A, et al. Antimicrobial susceptibility associated with bloodstream infections in children: a referral hospital-based study. Braz J Infect Dis 2013;17(4):497-9
   PubMed Web of Science ®Google Scholar
• Lutter SA, Currie ML, Mitz LB, et al. Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med 2005;159(10):924-8
   PubMed Web of Science ®Google Scholar
• Papadopoulou-Alataki E, Hassan A, Davies EG. Prevention of infection in children and adolescents with primary immunodeficiency disorders. Asian Pac J Allergy Immunol 2012;30(4):249-58
   PubMed Web of Science ®Google Scholar
• Ochs HD, Hitzig WH. History of primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol 2012;12(6):577-87
   PubMed Web of Science ®Google Scholar
• Yong PL, Boyle J, Ballow M, et al. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the primary immunodeficiency committee of the american academy of allergy asthma and immunology. Clin Immunol 2010;135(2):255-63
   PubMed Web of Science ®Google Scholar
• Efrati O, Gonik U, Bielorai B, et al. Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer. Pediatr Blood Cancer 2007;48(3):324-9
   PubMed Web of Science ®Google Scholar
• Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993;86(1):31-42
   PubMedGoogle Scholar
• Margolis DM, Melnick DA, Alling DW, et al. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 1990;162(3):723-6
   PubMed Web of Science ®Google Scholar
• Cheng CH, Tsai MH, Huang YC, et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics 2008;122(6):1212-17
   PubMed Web of Science ®Google Scholar
• Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101(25):2916-21
   PubMed Web of Science ®Google Scholar
• Mouy R, Fischer A, Vilmer E, et al. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989;114(4 Pt 1):555-60
   PubMed Web of Science ®Google Scholar
• Weening RS, Kabel P, Pijman P, et al. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr 1983;103(1):127-30
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Amano D, Ueda K, et al. Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP). Eur J Pediatr 1978;127(4):247-54
   PubMed Web of Science ®Google Scholar
• Petropoulou T, Liese J, Tintelnot K, et al. [Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease (CGD)]. Mycoses 1994;37(Suppl 2):64-9
   PubMed Web of Science ®Google Scholar
• Soroush S, Haghi-Ashtiani MT, Taheri-Kalani M, et al. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children’s Medical Center of Tehran: a 6-year prospective study. Acta Med Iran 2010;48(3):178-84
   PubMedGoogle Scholar